Roskamp Institute Announces New Class Of Drugs That Can Impact Alzheimer’s Disease

Share this postShare on Google+Share on LinkedInShare on FacebookTweet about this on TwitterEmail this to someone

On January 25th, we announceed the discovery of a new class of drugs that lower the production of the main pathological protein that causes Alzheimer’s diseas. Our annoucement got picked up in the press. Following is a roundup of press mentions: